A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...

Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

In 2023, Roche said it was removing TNKase for stroke from its phase 3 programmes after a readout of the TIMELESS trial, but ...

Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...

Ischemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...

RHHBY's member company, Genentech, obtains FDA nod for TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Ahead of the Champions Trophy 2025 semi-final, find out why cricket legends Sanjay Manjrekar and Anil Kumble want India ...

Heart attacks and strokes rise exponentially with age and make a major contribution to increasing healthcare costs and lost productivity. In the UK more than 7 million people are living with ...

The FDA said to stop all use of Philips' Tack Endovascular System, which is under class I recall for user difficulties in ...

Dr. Michael Chenier with Mission Hospital writes that knowing symptoms of heart disease and getting screened shoule be a ...